We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page.
Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site.
Oslo, November 3rd, 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes…
Read moreObserve Medical ASA invites you to a presentation of the third quarter 2020. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, November 3. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201103_4 Due to COVID-19 and corresponding…
Read moreObserve Medical ASA, October 30, 2020: On October 29, 2020, Observe Medical announced the signing of the final agreement to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). All conditions in the agreement is met, and…
Read moreQuarterly Presentation – Q4
Annual Report
Quarterly Presentation - Q1
Annual General Meeting
Half-yearly Report
Quarterly Presentation - Q3
Last updated 31 December 2020
| Name | Number of shares | % of top 20 | % of total | Country | |
|---|---|---|---|---|---|
| 1 | NAVAMEDIC ASA | 4,222,727 | 25.70% | 21.54% | Norway |
| 2 | INGERØ REITEN INV. COMPANY AS | 3,939,394 | 23.98% | 20.09% | Norway |
| 3 | RO, LARS | 1,500,000 | 9.13% | 7.65% | NORWAY |
| 4 | UBS SWITZERLAND AG | 1,420,522 | 8.65% | 7.25% | SWITZERLAND |
| 5 | ARTAL AS | 897,407 | 5.46% | 4.58% | Norway |
| 6 | ALPINE CAPITAL AS | 650,000 | 3.96% | 3.32% | Norway |
| 7 | Soleglad Invest AS | 586,668 | 3.57% | 2.99% | NORWAY |
| 8 | NORDA ASA | 516,570 | 3.14% | 2.63% | Norway |
| 9 | TRANBERGKOLLEN INVEST AS | 500,000 | 3.04% | 2.55% | Norway |
| 10 | LEIKERANE AS | 466,666 | 2.84% | 2.38% | Norway |
| 11 | LAPAS AS | 336,924 | 2.05% | 1.72% | Norway |
| 12 | MP PENSJON PK | 262,025 | 1.59% | 1.34% | NORWAY |
| 13 | KRAEBER VERWALTUNG GMBH | 214,850 | 1.31% | 1.10% | GERMANY |
| 14 | BUKKEVIK INVESTERING AS | 140,160 | 0.85% | 0.71% | norway |
| 15 | GINNY INVEST AS | 140,000 | 0.85% | 0.71% | Norway |
| 16 | Bjørntvedt, vegard | 136,358 | 0.83% | 0.70% | Norway |
| 17 | BJØRNTVEDT, EIVIND | 130,000 | 0.79% | 0.66% | norway |
| 18 | NORDNET BANK AB | 125,572 | 0.76% | 0.64% | sweden |
| 19 | philip invest as | 125,000 | 0.76% | 0.64% | Norway |
| 20 | ABC INVEST AS | 120,000 | 0.73% | 0.61% | norway |
| Total numBer owned by top 20 | 16,430,843 | 100.00% | 83.81% | ||
| Total number of shares | 19,605,457 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Euronext Expand Oslo
OBSRV
4 November 2019
Healthcare
NOK
NO0010865009
19 605 457
NOK 0.26
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com